Administering systemic chemotherapy improves survival for patients with resectable CRCLM

Immunotherapy significantly increases the number of patients free from bowel cancer

ASCO 2024: Highlights and analysis

Nivolumab plus ipilimumab shows clinical benefit as first-line treatment for centrally confirmed MSI-H/dMMR mCRC

Avelumab combined with regorafenib shows improved outcome in solid tumours with tertiary lymphoid structures

Nab-paclitaxel as first line treatment of gastrointestinal neuroendocrine carcinomas shows efficacious results

Trifluridine/tipiracil and bevacizumab combination gives a prolonged PFS compared to trifluridine/tipiracil monotherapy in mCRC

Combination of cabozantinib and atezolizumab shows moderate activity in treating metastatic adrenocortical carcinoma

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC

Gastro-intestinal endoscopy capacity in Nigeria: strengths and challenges

Colorectal cancer risk factors in Nigeria

ESMO 2023: Highlights and analysis